Cargando…
EGb 761(®) Does Not Affect Blood Coagulation and Bleeding Time in Patients with Probable Alzheimer’s Dementia—Secondary Analysis of a Randomized, Double-Blind Placebo-Controlled Trial
Following reports of bleeding upon Ginkgo intake, we assessed whether Ginkgo extract EGb 761(®) affects coagulation or platelet function or increases the risk of bleeding. In a double-blind, placebo-controlled trial, prothrombin time, activated partial thromboplastin time, international normalized r...
Autores principales: | Kloft, Charlotte, Hoerr, Robert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8701823/ https://www.ncbi.nlm.nih.gov/pubmed/34946404 http://dx.doi.org/10.3390/healthcare9121678 |
Ejemplares similares
-
Treatment of Vertigo: A Randomized, Double-Blind Trial Comparing Efficacy and Safety of Ginkgo biloba Extract EGb 761 and Betahistine
por: Sokolova, Larysa, et al.
Publicado: (2014) -
Antiapoptotic Effects of EGb 761
por: Serrano-García, Norma, et al.
Publicado: (2013) -
Alleviating neuropsychiatric symptoms in dementia: the effects of Ginkgo biloba extract EGb 761(®). Findings from a randomized controlled trial
por: Bachinskaya, Natalia, et al.
Publicado: (2011) -
Single and Repeated Doses of EGb 761(®) do not Affect Pharmacokinetics or Pharmacodynamics of Rivaroxaban in Healthy Subjects
por: Hoerr, Robert, et al.
Publicado: (2022) -
Ginkgo biloba Extract EGb 761 in the Treatment of Patients with Mild Neurocognitive Impairment: A Systematic Review
por: Hort, Jakub, et al.
Publicado: (2023)